In vivo xenograft models, where human leukemia cells are implanted into immunocompromised mice, have become indispensable tools in preclinical oncology research. These models offer a physiologically relevant environment to study tumor biology, drug efficacy, and resistance mechanisms in ways that in vitro cultures cannot replicate. Leukemia xenografts can be established using either subcutaneous implantation, which…
Acute Myeloid Leukemia (AML) and Chronic Myeloid Leukemia (CML) are both malignancies arising from myeloid lineage cells but differ significantly in pathogenesis, progression, and treatment response. AML is characterized by the rapid accumulation of immature myeloid blasts, leading to bone marrow failure. CML involves the gradual expansion of mature granulocytes driven by the BCR-ABL fusion…
CRISPR-Cas9 technology has revolutionized gene editing by providing precise, efficient tools to modify the genome. However, applying CRISPR to suspension cells such as leukemia and lymphoma lines remains technically challenging. These cells’ non-adherent nature and sensitivity to physical and chemical manipulation require specialized protocols to achieve effective gene editing without compromising cell viability. The most…
Small interfering RNA (siRNA) technology enables targeted gene silencing by harnessing the cell’s natural RNA interference pathway. This approach allows researchers to transiently reduce or eliminate the expression of genes of interest, providing powerful insights into gene function and disease mechanisms. In leukemia research, siRNA knockdown helps dissect the roles of oncogenes, tumor suppressors, signaling…
Gene delivery into leukemia cells is critical for functional genomics, drug target validation, and therapeutic development. Among the many transfection techniques, electroporation and lipofection are the two most commonly employed methods, each with distinct advantages and limitations. Lipofection uses cationic lipid molecules to form complexes with negatively charged nucleic acids, facilitating their uptake into cells…
Transfecting blood-derived cells—particularly leukemia and lymphoma cell lines—poses a unique set of challenges for researchers. Unlike adherent cells such as fibroblasts or epithelial lines, blood cells grow in suspension, lack strong cell–cell contact, and have distinct membrane properties that make them resistant to conventional transfection techniques like lipofection or calcium phosphate precipitation. Their high proliferation…
Co-transfection refers to the process of simultaneously transfecting cells with more than one type of plasmid DNA or RNA molecule. This technique is often used in experiments where the expression of multiple genes is required. For instance, co-transfection is commonly used in experiments involving gene interaction studies, protein complex formation, CRISPR-Cas9 gene editing, and reprogramming…
Gene editing refers to techniques that allow scientists to add, delete, or modify DNA at specific sites in the genome. The most widely used system for gene editing as of my last training cut-off in September 2021 is the CRISPR-Cas9 system. This system has revolutionized the field of molecular biology due to its simplicity, efficiency,…
Gene therapy is a rapidly developing field that involves the introduction or alteration of genetic material within a person’s cells to treat or prevent disease. DNA transfection reagents play a crucial role in gene therapy by delivering therapeutic genes into target cells. Here are some examples of gene therapy applications where DNA transfection reagents can…
